Filing Details
- Accession Number:
- 0001019056-13-001031
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-09-16 15:23:18
- Reporting Period:
- 2013-09-13
- Filing Date:
- 2013-09-16
- Accepted Time:
- 2013-09-16 15:23:18
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 792641 | Bio Reference Laboratories Inc | BRLI | Services-Medical Laboratories (8071) | 222405059 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1189454 | Howard Dubinett | 481 Edward H. Ross Drive Elmwood Park NJ 07407 | Executive Vp, Coo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2013-09-13 | 20,000 | $29.40 | 345,138 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- The price reported in Column 4 is a weighted average price. These shares were sold in more than one transaction at price ranging from $29.34 to $29.43, inclusive. The reporting person undertakes to provide to Bio-Reference Laboratories, Inc., any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Billionaire Hedge Funds
